Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-B7-1 Antibody-PE (4I630)
🥰Excellent
Catalog No. TMAY-01080P
Anti-B7-1 Antibody-PE (4I630) is a PE-conjugated Mouse antibody targeting B7-1. Anti-B7-1 Antibody-PE (4I630) can be used in FCM.
Anti-B7-1 Antibody-PE (4I630)
Anti-B7-1 Antibody-PE (4I630)
🥰Excellent
Catalog No. TMAY-01080P
Anti-B7-1 Antibody-PE (4I630) is a PE-conjugated Mouse antibody targeting B7-1. Anti-B7-1 Antibody-PE (4I630) can be used in FCM.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-B7-1 Antibody-PE (4I630) is a PE-conjugated Mouse antibody targeting B7-1. Anti-B7-1 Antibody-PE (4I630) can be used in FCM. |
| Ig Type | Monoclonal Mouse IgG1 |
| Clone | 4I630 |
| Reactivity | Human |
| Verified Activity | Profile of anti-B7-1 (CD80) reactivity on Daudi cells analyzed by flow cytometry. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD80 / B7-1 (rh CD80 / B7-1; TMPY-01063; NP_005182.1; Met1-Asn242) and conjugated with PE under optimum conditions, the unreacted PE was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: IHC AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy |
| Conjucates | PE |
| Others Formats | Unconjugated/Biotin/FITC |
| Antibody Types Available | 4 |
| Immunogen | Recombinant Human CD80 / B7-1 protein (TMPY-01063) |
| Antigen Species | Human |
| Biology Area | Cancer Drug Targets |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-B7-1 Antibody-PE (4I630) | purchase Anti-B7-1 Antibody-PE (4I630) | Anti-B7-1 Antibody-PE (4I630) cost | order Anti-B7-1 Antibody-PE (4I630)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.